Update on Novel Hormonal and Nonhormonal Male Contraceptive Development.

Published in: The Journal of clinical endocrinology and metabolism (2021)

NICHD supports development of reversible male contraceptive agents. Other organizations such as the World Health Organization, the Population Council, and the Male Contraception Initiative are pursuing male contraceptive development, but industry involvement remains limited.

Keyphrases

metabolic syndrome
adipose tissue
insulin resistance
polycystic ovary syndrome